Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

von Hippel-Lindau Disease 1Sebaceous Cell Tumor of Eyelid 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Neoplasms 1Hematologic Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenomyosis 1

Interventions

Blood Specimen Collection 2gallium Ga 68 dotatate 1belzutifan 1Sunitinib 1Propranolol 1Magnetic Resonance Spectroscopy 1Exome Sequencing 1Bevacizumab 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × von Hippel-Lindau Disease × Exome Sequencing × Clear all
NCT03979833 2019-09-27

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

University of Copenhagen

Unknown
10 enrolled

von Hippel-Lindau Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡